FDA clears Radiotherapy planning software:
This article was originally published in Clinica
MDS Nordion's Helax-TMS V5.0 treatment planning software with segmented intensity modulated radiation therapy (IMRT) has received 510(k) clearance from the US FDA. The Canadian company's radiotherapy planning procedure is particularly effective for head, neck and prostate cancers which are difficult to treat with current technology without damaging surrounding healthy tissue. The software is able to do inverse planning, a tool provided to create plans intended for IMRT treatment delivery.